TE_58

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family SVA_E
TE superfamily SVA
TE class Retroposon
Gene ACOT7
Class Chimeric
Coding Non-coding
Tumor-specific score 1.38
Counts of samples TCGA_tumor:215; TCGA_normal:3; GTEx:173
TSS chr1(-):6305507



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_58.1 ACOT7 Chimeric Non-coding Non-coding chr1(-):6264675,6264695,6281102,6281286,6294864,6294980,6305420,6305508
teRNA_58.2 ACOT7 Chimeric Non-coding Non-coding chr1(-):6264675,6264695,6281102,6281286,6282724,6282796,6294864,6294980,6305420,6305508
teRNA_58.3 ACOT7 Chimeric Non-coding Non-coding chr1(-):6264675,6264695,6281102,6281286,6282724,6282888,6294864,6294980,6305420,6305508
teRNA_58.4 ACOT7 Chimeric Non-coding Non-coding chr1(-):6281266,6281286,6294864,6294980,6305420,6305508


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).